Table 3.
Expression, immune response, clinical correlation and function of ENOA in cancer
| Cancer Tissue | Expression | Immune response | Clinical correlation | Function |
|---|---|---|---|---|
| Brain |
mRNA [152] |
|
|
|
| Bone |
protein [170] |
|
Prognosis [170] |
|
| Breast |
mRNA, protein [164,167,177] |
Ab [178,179] |
Prognosis, Survival [167,178] |
Chemoresistance, Metastasis [167,177,178] |
| Colon |
mRNA, protein [152,158,168] |
|
|
|
| Gastric |
mRNA, protein [152,162,169] |
T cells [180] |
|
|
| Head and neck |
mRNA, protein [155,166,171] |
Ab [119,120] |
Prognosis [166] |
Metastasis [166] |
| Hematopoietic system |
protein [160] |
Ab [181] |
|
|
| Liver |
mRNA, protein [130,152,156,165] |
|
Prognosis [156,165] |
Growth, Metastasis [156] |
| Lung |
mRNA, protein [152,159,172,174,182] |
Ab [159,172,178,183,184] |
Prognosis, Survival [172,174,178] |
|
| Ovary |
mRNA, protein [152,153] |
|
|
|
| Pancreas |
mRNA, protein [152,154,161,163] |
Ab and T cells [154,185,186] |
Survival [185] |
|
| Prostate |
mRNA, protein [152,187] |
|
|
|
| Skin | mRNA [173] | Ab [173,188] |